TrianglePUBLICATIONS · 36302175
A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Clin Cancer Res
- Publication date
- 2023 Jan 17
- First author
- Ligon JA
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Ligon JA
- type
- Author
- name
- Sundby RT
- type
- Author
- name
- Wedekind MF
- type
- Author
- name
- Arnaldez FI
- type
- Author
- name
- Del Rivero J
- type
- Author
- name
- Wiener L
- type
- Author
- name
- Srinivasan R
- type
- Author
- name
- Spencer M
- type
- Author
- name
- Carbonell A
- type
- Author
- name
- Lei H
- type
- Author
- name
- Shern J
- type
- Author
- name
- Steinberg SM
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Ligon JA
- type
- Author
- name
- Sundby RT
- type
- Author
- name
- Wedekind MF
- type
- Author
- name
- Arnaldez FI
- type
- Author
- name
- Del Rivero J
- type
- Author
- name
- Wiener L
- type
- Author
- name
- Srinivasan R
- type
- Author
- name
- Spencer M
- type
- Author
- name
- Carbonell A
- type
- Author
- name
- Lei H
- type
- Author
- name
- Shern J
- type
- Author
- name
- Steinberg SM
- type
- Author
- bibliography ids
- nci-bib-5010cb374606e3e4bf013bc5
- book metadata
- content sha256
- f85a6d356dee74809e05729af8d25552442f210f129ba29ac6e2d9db4fd07c08
- document type
- citation
- dois
- 10.1158/1078-0432.CCR-22-2168
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:36302175
- immutable id
- pubmed:36302175@f85a6d356dee74809e05729af8d25552442f210f129ba29ac6e2d9db4fd07c08
- journal
- abbreviation
- Clin Cancer Res
- issn electronic
- 1557-3265
- issn print
- 1078-0432
- issue
- 2
- name
- Clinical cancer research : an official journal of the American Association for Cancer Research
- nlm unique id
- 9502500
- pages
- 341-348
- volume
- 29
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 36302175
- provenance
- batch id
- d370e99271168e8a8a13
- provider
- NCBI PubMed ESummary
- record sha256
- bd3c10a35b2e5db10e21995de4e48d3153642cd69bbb1033cbbe0af3d31d4dba
- response sha256
- f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
- retrieved at
- 2026-09-09T23:48:13.005737+00:00
- publication date
- display
- 2023 Jan 17
- precision
- day
- year
- 2023
- publication types
- Clinical Trial, Phase II
- Journal Article
- Research Support, N.I.H., Intramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma.
Preserved source evidence · Not medical advice